Gwen E Weld's most recent trade in Nautilus Biotechnology Inc was a trade of 160,000 Stock Option (Right to Buy) done . Disclosure was reported to the exchange on March 3, 2025.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Nautilus Biotechnology Inc | Gwen E. Weld | Chief People Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Mar 2025 | 160,000 | 160,000 | - | - | Stock Option (Right to Buy) | |
| Nautilus Biotechnology Inc | Gwen E. Weld | Chief People Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Mar 2024 | 160,000 | 160,000 | - | - | Stock Option (Right to Buy) | |
| Nautilus Biotechnology Inc | Gwen E. Weld | Chief People Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 27 Feb 2023 | 160,000 | 160,000 | - | - | Stock Option (Right to Buy) | |
| Nautilus Biotechnology Inc | Gwen E. Weld | Chief People Officer | Purchase of securities on an exchange or from another person at price $ 2.03 per share. | 23 Sep 2022 | 30,000 | 30,000 | - | 2.0 | 60,765 | Common Stock |
| Nautilus Biotechnology Inc | Gwen E. Weld | Chief People Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 May 2022 | 375,000 | 375,000 | - | - | Stock Option (Right to Buy) |